查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947120

2026年全球性行为感染（STI）及阴道炎聚合酵素链锁反应（PCR）检测市场报告

Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场发展迅速，预计将从2025年的6.8亿美元增长到2026年的7.5亿美元，复合年增长率（CAGR）为10.3%。过去几年的增长可归因于多种因素，例如性行为感染的日益流行、传统诊断方法的局限性、女性生殖健康意识的提高、临床诊断检查室的扩张以及标准PCR检测通讯协定的采用。

预计未来几年，性行为感染(STI) 和阴道炎聚合酵素链锁反应(PCR) 检测市场将强劲成长，到 2030 年市场规模将达到 10.8 亿美元，复合年增长率 (CAGR) 为 9.5%。预测期内的成长要素包括：对照护现场分子诊断的需求不断增长、多重 PCR 和即时PCR技术的进步、居家检测解决方案的日益普及、分子诊断基础设施投资的增加以及性行为感染和阴道炎筛检计画的扩展。预测期内的主要趋势包括：用于性行为感染和阴道炎检测的多重 PCR 检测板的广泛应用、对快速灵敏的分子诊断技术的日益青睐、对居家和自采样 PCR检测套组的需求不断增长、PCR 检测在女性常规健康检查中的应用范围扩大，以及对早期病原体准确鑑定的日益重视。

性健康筛检频率的不断提高预计将推动性行为感染(STI) 和阴道炎聚合酵素链锁反应(PCR) 检测市场的成长。性行为感染传染感染筛检是一种医学评估，旨在检测性行为感染感染及相关疾病，从而实现早期诊断、适当治疗和预防疾病传播。筛检增加的主要驱动因素是全球性行为感染的上升，这凸显了快速且准确检测的必要性，以最大限度地减少併发症并遏制疾病的进一步传播。 PCR 检测在这方面发挥着至关重要的作用，因为它能够准确识别病原体，即使是无症状感染者也能检测到，有助于早期疗育。例如，根据英国政府官方网站 (GOV.UK) 的数据，截至 2025 年 6 月，英国新增性传染感染病例数预计将从 2023 年的 399,947 例下降 8.8% 至 2024 年的 364,750 例，这反映了检测力度加大带来的正面影响。因此，性健康检测的增加推动了性传染感染和阴道炎 PCR 检测市场的扩张。

性行为感染(STI) 和阴道炎 PCR 检测市场的主要企业正在开发多重即时PCR检测等技术，以满足对快速、准确和全面的病原体检测日益增长的需求。多重 PCR 可在单次检测中同时扩增和鑑定多种病原体的 DNA 或 RNA，与传统的单一病原体检测相比，可缩短检测週期并降低成本。此方法还提高了灵敏度和特异性，能够检测到传统培养沙眼披衣菌显微镜检查可能遗漏或难以检测的低浓度病原体遗传物质（包括合併感染）。例如，2023 年 2 月，美国生物技术公司 Thermo Fisher Scientific 推出了 Applied Biosystems Trumark STI Select Panel，这是一种多重即时即时PCR检测，可同时检测四种主要的性行为感染：霉浆菌和生殖支原体。该测试是为研究目的而开发的，代表了分子性传播感染诊断的重大进步，可提供更快、更灵敏的诊断，并优化检查室工作流程以改善临床结果。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球性行为感染（STI）及阴道炎聚合酵素链锁反应（PCR）检测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 多重PCR检测板在性行为感染传染病和阴道炎检测的应用日益广泛
    • 对快速灵敏的分子诊断的需求日益增长
    • 家用和自采样PCR检测套组的需求不断增长
    • 在女性常规健康检查中扩大PCR检测范围
    • 越来越重视早期准确识别病原体

第五章 终端用户产业市场分析

  • 医院和诊所
  • 诊断检查室
  • 居家医疗或家庭检测服务提供者
  • 公共卫生和筛检项目
  • 研究和学术机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场规模、比较和成长率分析
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场表现：规模和成长，2020-2025年
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场预测：规模和成长，2025-2030年，2035年

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按测试类型
  • 性行为感染传染病（STR）聚合酵素链锁反应（PCR）检测组，阴道炎聚合酵素链锁反应（PCR）检测组
  • 因疾病
  • 性行为感染传染病、阴道感染疾病
  • 最终用户
  • 医院/诊所、诊断检查室、居家医疗或家庭检测以及其他最终用户
  • 按类型细分：性行为感染传染病（STR）聚合酵素链锁反应（PCR）检测组
  • 披衣菌感染衣原体聚合酵素链锁反应、淋病聚合酵素链锁反应、阴道毛滴虫聚合酵素链锁反应、单纯疱疹病毒聚合酵素链锁反应、人类乳头瘤病毒聚合酵素链锁反应、霉浆菌支原体聚合酵素链锁反应、梅毒聚合酵素链锁反应、多重性性行为感染聚合酵素链锁反应检测
  • 按类型细分：阴道炎聚合酵素链锁反应(PCR) 检测组
  • 细菌性阴道炎聚合酵素链锁反应、念珠菌性聚合酵素链锁反应聚合酵素链锁反应、滴虫性阴道炎聚合酶炼式反应、混合性阴道炎聚合酵素链锁反应检测、需氧性阴道炎聚合酵素链锁反应、萎缩性阴道炎聚合酵素链锁反应

第十章 区域与国家分析

  • 全球性行为感染（STI）及阴道炎聚合酵素链锁反应（PCR）检测市场按地区划分、绩效及预测（2020-2025年、2025-2030年、2035年）
  • 全球性行为感染（STI）及阴道炎聚合酵素链锁反应（PCR）检测市场依国家/地区划分、绩效及预测（2020-2025年、2025-2030年、2035年）

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：竞争格局和市场份额，2024年
  • 性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：公司估值矩阵
  • 性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Becton Dickinson and Company

第37章：其他领先和创新企业

  • Hologic Inc., QIAGEN NV, ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC SL, ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：提供新机会的国家
  • 2030年性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：提供新机会的细分市场
  • 2030年性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MSTIS02_G26Q1

Sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing is a highly accurate molecular diagnostic technique that amplifies and detects the genetic material of pathogens responsible for sexually transmitted and vaginal infections. This method allows for rapid identification of bacteria, viruses, and other microorganisms, enabling healthcare providers to diagnose infections effectively and customize treatments.

The primary test types for STI and vaginitis PCR testing include STI PCR panels and vaginitis PCR panels. STIs are infections caused by bacteria, viruses, fungi, or parasites, primarily transmitted through sexual contact, including vaginal, anal, and oral sex. These tests cover a broad spectrum of sexually transmitted and vaginal infections and are used by various end users such as hospitals and clinics, diagnostic laboratories, and homecare or at-home testing services.

Tariffs are impacting the sti and vaginitis pcr testing market by increasing the cost of imported reagents, pcr instruments, and molecular consumables, thereby raising overall testing expenses. Diagnostic laboratories and homecare testing segments are particularly affected, with asia-pacific and emerging markets facing higher import duties on molecular diagnostics. These cost pressures have led to pricing adjustments and slower adoption in cost-sensitive regions. However, tariffs have also encouraged local manufacturing of pcr kits and reagents, fostering regional self-reliance and strengthening domestic diagnostic capabilities.

The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market statistics, including sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing industry global market size, regional shares, competitors with a sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market share, detailed sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing industry. This sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market size has grown rapidly in recent years. It will grow from $0.68 billion in 2025 to $0.75 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing prevalence of sexually transmitted infections, limitations of traditional diagnostic methods, growing awareness of women's reproductive health, expansion of clinical diagnostic laboratories, adoption of standard pcr testing protocols.

The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market size is expected to see strong growth in the next few years. It will grow to $1.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rising demand for point-of-care molecular diagnostics, technological advancements in multiplex and real-time pcr, increasing adoption of home-based testing solutions, growing investments in molecular diagnostic infrastructure, expanding screening programs for sti and vaginitis. Major trends in the forecast period include rising adoption of multiplex pcr panels for sti and vaginitis detection, increasing preference for rapid and high-sensitivity molecular diagnostics, growing demand for at-home and self-collected pcr testing kits, expansion of pcr testing in routine women's health screening, enhanced focus on early and accurate pathogen identification.

The rising frequency of sexual health screenings is expected to drive growth in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market. Sexual health screenings are medical evaluations performed to detect STIs and related conditions, enabling early diagnosis, timely treatment, and prevention of disease transmission. The increase in screenings is largely due to the global rise in STIs, which underscores the need for prompt and accurate detection to minimize complications and curb further spread. PCR testing plays a vital role in this context by allowing precise identification of pathogens, often even in asymptomatic individuals, facilitating early intervention. For instance, in June 2025, according to GOV.UK, new STI diagnoses in the UK declined by 8.8%, from 399,947 cases in 2023 to 364,750 cases in 2024, reflecting the impact of enhanced screening efforts. Therefore, the growth in sexual health screenings is propelling the expansion of the STI and vaginitis PCR testing market.

Major players in the sexually transmitted infection (STI) and vaginitis PCR testing market are developing technologies like multiplex real-time PCR assays to meet the increasing demand for fast, precise, and comprehensive pathogen detection. Multiplex PCR allows for the simultaneous amplification and identification of DNA or RNA from multiple pathogens within a single test, lowering both turnaround time and costs compared to traditional single-pathogen assays. This method also enhances sensitivity and specificity, enabling the detection of low levels of pathogen genetic material-even in co-infections-that conventional culture or microscopy techniques might overlook or detect less accurately. For instance, in February 2023, Thermo Fisher Scientific, a US-based biotechnology company, introduced the Applied Biosystems TrueMark STI Select Panel, a multiplex real-time PCR assay designed to concurrently detect four prevalent STIs: Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. Intended for research purposes, this test improves clinical outcomes by offering faster, highly sensitive diagnostics while optimizing laboratory workflows, marking a notable advancement in molecular STI diagnostics.

In December 2024, OraSure Technologies, a US-based medical device and diagnostics company, acquired Sherlock Biosciences for an undisclosed sum. Through this acquisition, OraSure seeks to broaden its molecular diagnostics offerings in sexual health by incorporating Sherlock's rapid, self-collected STI testing solutions and advancing its entry into the over-the-counter diagnostics market. Sherlock Biosciences, also based in the US, specializes in PCR-based testing for sexually transmitted infections (STIs) and vaginitis.

Major companies operating in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., Bioperfectus Technologies Co. Ltd.

North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2025. The regions covered in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market consists of revenues earned by entities by providing services such as clinical consultations, comprehensive screening tests, multiplex testing, treatment monitoring, and sample collection guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market also includes sales of nucleic acid extraction kits, positive and negative control materials, automated PCR analyzers, and single-pathogen PCR test kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels; Vaginitis Polymerase Chain Reaction (PCR) Panels
  • 2) By Condition: Sexually Transmitted Infections; Vaginal Infections
  • 3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Or At-Home Testing; Other End Users
  • Subsegments:
  • 1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction; Neisseria Gonorrhoeae Polymerase Chain Reaction; Trichomonas Vaginalis Polymerase Chain Reaction; Herpes Simplex Virus Polymerase Chain Reaction; Human Papillomavirus Polymerase Chain Reaction; Mycoplasma Genitalium Polymerase Chain Reaction; Syphilis Polymerase Chain Reaction; Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
  • 2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction; Candida Species Polymerase Chain Reaction; Trichomoniasis Polymerase Chain Reaction; Mixed Vaginitis Polymerase Chain Reaction Panels; Aerobic Vaginitis Polymerase Chain Reaction; Atrophic Vaginitis Polymerase Chain Reaction
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company; Hologic Inc.; QIAGEN N.V.; ARUP Laboratories Inc.; Seegene Inc.; LetsGetChecked Ltd.; Sansure Biotech Inc.; Visby Medical Inc.; R-Biopharm AG; Savyon Diagnostics Ltd.; altona Diagnostics GmbH; SpeeDx Pty Ltd.; CERTEST BIOTEC S.L.; ALPCO Diagnostics; Atila Biosystems Inc.; Ridacom Diagnostics Ltd.; Sinochips Diagnostics Co Ltd.; Vitassay S.L.; Bioperfectus Technologies Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Multiplex Pcr Panels For Sti And Vaginitis Detection
    • 4.2.2 Increasing Preference For Rapid And High-Sensitivity Molecular Diagnostics
    • 4.2.3 Growing Demand For At-Home And Self-Collected Pcr Testing Kits
    • 4.2.4 Expansion Of Pcr Testing In Routine Women'S Health Screening
    • 4.2.5 Enhanced Focus On Early And Accurate Pathogen Identification

5. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Homecare Or At-Home Testing Providers
  • 5.4 Public Health And Screening Programs
  • 5.5 Research And Academic Institutes

6. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Segmentation

  • 9.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, Vaginitis Polymerase Chain Reaction (PCR) Panels
  • 9.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sexually Transmitted Infections, Vaginal Infections
  • 9.3. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Homecare Or At-Home Testing, Other End Users
  • 9.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chlamydia Trachomatis Polymerase Chain Reaction, Neisseria Gonorrhoeae Polymerase Chain Reaction, Trichomonas Vaginalis Polymerase Chain Reaction, Herpes Simplex Virus Polymerase Chain Reaction, Human Papillomavirus Polymerase Chain Reaction, Mycoplasma Genitalium Polymerase Chain Reaction, Syphilis Polymerase Chain Reaction, Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
  • 9.5. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Vaginitis Polymerase Chain Reaction (PCR) Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bacterial Vaginosis Polymerase Chain Reaction, Candida Species Polymerase Chain Reaction, Trichomoniasis Polymerase Chain Reaction, Mixed Vaginitis Polymerase Chain Reaction Panels, Aerobic Vaginitis Polymerase Chain Reaction, Atrophic Vaginitis Polymerase Chain Reaction

10. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Regional And Country Analysis

  • 10.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 11.1. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 12.1. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 13.1. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 14.1. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 15.1. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 16.1. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 17.1. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 18.1. Taiwan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 19.1. South East Asia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 20.1. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 21.1. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 22.1. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 23.1. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 24.1. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 25.1. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 26.1. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 27.1. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 28.1. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 29.1. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 30.1. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 31.1. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 32.1. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 33.1. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 34.1. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Condition, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Regulatory and Investment Landscape

36. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Company Profiles

  • 36.1. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Other Major And Innovative Companies

  • Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd.

38. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

40. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer